Journal of Young Pharmacists logo
Submit
Journal of Young PharmacistsACADEMIC PUBLISHING
Review

Plasmalogen as Therapeutics to Neurodegenerative Disorders

1, 1★★ Corresponding author

  1. 1Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Kolkata, West Bengal, INDIA.

CORRESPONDENCE

Sugato Banerjee

Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Kolkata, West Bengal, INDIA.

banerjeesugato1@gmail.com

Received: 29-07-2022; Revised: 28-09-2022; Accepted: 09-10-2022.

Volume 15, Issue 1 · pp. 31-36 · 2022 · DOI: 10.5530/097515050475

ABSTRACT

Plasmalogens, glycerophospholipids, can alleviate Parkinson's and Alzheimer's disease. It helps in neural communication, such as vesicular or membrane fusion and ion transport. It counteracts oxidative stress by acting on Reactive Oxygen Species (ROS). Plasmalogens may improve memory in Alzheimer's patients as observed using Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog). Plasmalogens are usually isolated from Ascidians and Scallops. In the current review, we discuss the role of plasmalogen in neurodegenerative disorders.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Vesmaker, K., & Banerjee, S. (2022). Plasmalogen as Therapeutics to Neurodegenerative Disorders. Journal of Young Pharmacists, 15(1), 31-36. https://doi.org/10.5530/097515050475

    Copyright and licence

    © 2022 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0